Monkeypox Vaccine: After the coronavirus, now the cases of monkeypox are increasing rapidly in many countries of the world. The threat of this virus has started increasing in India too. Amidst all this, the discussion about the monkeypox vaccine has started gaining momentum. In this episode, Serum Institute of India CEO Adar Poonawalla held a meeting with Union Health Minister Mansukh Mandaviya on Tuesday.

Serum Institute of India CEO Adar Poonawalla after meeting Union Health Minister Mansukh Mandaviya said that my meeting was good as always. In view of the increasing threat of monkeypox, all preparations for the vaccine are being done. I informed the Union Minister about this. Adar Poonawalla said that we are researching the vaccine for monkeypox. Where it is needed, it will be made available. He said that monkeypox has been present in the world for a long time. However, the possibility of it taking the form of an epidemic like corona virus is less. He said that cases of monkeypox infection have also been reported in India. But, we are working on the vaccine and the vaccine will be available in a few months.

According to the information coming out in the midst of all this, a Danish company has made a monkeypox vaccine. However, no information is available about its Affiliate data yet. However, this vaccine has been approved in the European Union. After this, the discussion about this vaccine has intensified all over the world. The name of the company that makes the vaccine is Bavarian Nordic. It is believed that work can be started soon to investigate the efficacy data of this vaccine.